A detailed history of Tower Research Capital LLC (Trc) transactions in Annexon, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 15,881 shares of ANNX stock, worth $104,020. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15,881
Previous 7,014 126.42%
Holding current value
$104,020
Previous $50,000 54.0%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$4.33 - $6.79 $38,394 - $60,206
8,867 Added 126.42%
15,881 $77,000
Q1 2024

May 15, 2024

SELL
$4.03 - $7.81 $19,787 - $38,347
-4,910 Reduced 41.18%
7,014 $50,000
Q4 2023

Feb 13, 2024

BUY
$1.63 - $4.63 $6,749 - $19,172
4,141 Added 53.21%
11,924 $54,000
Q3 2023

Nov 14, 2023

BUY
$2.13 - $3.84 $8,360 - $15,072
3,925 Added 101.74%
7,783 $18,000
Q2 2023

Aug 14, 2023

SELL
$2.1 - $6.37 $8,681 - $26,333
-4,134 Reduced 51.73%
3,858 $13,000
Q1 2023

May 09, 2023

BUY
$3.74 - $7.46 $7,117 - $14,196
1,903 Added 31.25%
7,992 $31,000
Q4 2022

Feb 10, 2023

SELL
$4.56 - $6.61 $10,652 - $15,440
-2,336 Reduced 27.73%
6,089 $31,000
Q3 2022

Nov 10, 2022

BUY
$3.75 - $6.63 $6,645 - $11,748
1,772 Added 26.63%
8,425 $52,000
Q2 2022

Aug 15, 2022

BUY
$2.11 - $4.06 $94 - $182
45 Added 0.68%
6,653 $25,000
Q1 2022

May 12, 2022

BUY
$2.73 - $11.94 $7,518 - $32,882
2,754 Added 71.46%
6,608 $18,000
Q4 2021

Feb 14, 2022

BUY
$11.49 - $22.0 $31,000 - $59,356
2,698 Added 233.39%
3,854 $44,000
Q3 2021

Nov 15, 2021

SELL
$16.35 - $23.4 $12,524 - $17,924
-766 Reduced 39.85%
1,156 $22,000
Q2 2021

Aug 16, 2021

BUY
$17.81 - $27.48 $9,813 - $15,141
551 Added 40.19%
1,922 $43,000
Q1 2021

May 17, 2021

BUY
$22.0 - $35.01 $15,840 - $25,207
720 Added 110.6%
1,371 $38,000
Q4 2020

Feb 16, 2021

SELL
$20.81 - $30.55 $37,978 - $55,753
-1,825 Reduced 73.71%
651 $16,000
Q3 2020

Nov 16, 2020

BUY
$17.5 - $30.23 $43,330 - $74,849
2,476 New
2,476 $75,000

Others Institutions Holding ANNX

About Annexon, Inc.


  • Ticker ANNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,617,700
  • Market Cap $312M
  • Description
  • Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...
More about ANNX
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.